A blood test, combined with a risk model based on an individual's history, more accurately determines who is likely to benefit from lung cancer screening than the current U.S. recommendation, according to a study published today in the Journal of Clinical Oncology led by researchers from The University of Texas MD Anderson Cancer Center.
A new research has found that a blood test, combined with a risk model based on an individual history, more accurately determines who is likely to benefit fro
A new research has found that a blood test, combined with a risk model based on an individual s history, more accurately determines who is likely to benefit from lung cancer screening.